Bank OZK’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.6M Buy
15,448
+126
+0.8% +$29.1K 1.09% 28
2026
Q2
$3.25M Buy
15,322
+750
+5% +$147K 0.96% 31
2026
Q1
$2.86M Buy
14,572
+214
+1% +$41.6K 1.01% 35
2025
Q4
$2.49M Sell
14,358
-73
-0.5% -$13.3K 0.88% 37
2025
Q3
$2.75M Buy
14,431
+629
+5% +$112K 0.97% 32
2025
Q2
$2.48M Buy
13,802
+1,571
+13% +$273K 0.95% 34
2025
Q1
$2.07M Buy
+12,231
New +$2.01M 0.86% 40

Other funds holding DGX

Bank OZK's DGX Position: Q3 2026 in Review

Bank OZK increased its Quest Diagnostics (DGX) stake by 0.82% in Q3 2026, buying an estimated $29.1K and bringing the position to 15,448 shares worth $3.6M. The position accounts for 1.09% of the portfolio, ranked #28.

Bank OZK first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Bank OZK held 15,448 shares of Quest Diagnostics worth $3.6M as of Q3 2026.
  • Bank OZK bought 126 Quest Diagnostics shares in Q3 2026, an estimated $29.1K.
  • Quest Diagnostics made up 1.09% of Bank OZK's portfolio in Q3 2026, its #28 holding.
  • Bank OZK first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
  • 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Bank OZK's 13F filing for Q3 2026, filed 16 Nov 2026.